Samuel Montgomery, MD
Ophthalmology · Clinton, SCNPI 1467488551
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Alcon at 34.5% of the total. Reporting peaked in 2019 at $1,445 and has fallen 61.4% since, to $558 in 2025.
Across 256 payments — averaging $28.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Sun Pharmaceutical Industries Inc.$751
- AbbVie$445
- Carl Zeiss Meditec USA, Inc.$402
- NEW World Medical,inc.$276
- Novartis$256
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,08198%
- Education$1382%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 63 | $2,499 |
| Sun Pharmaceutical Industries Inc. | 50 | $751 |
| AbbVie(2 entities) | 21 | $445 |
| Carl Zeiss Meditec USA, Inc. | 5 | $402 |
| NEW World Medical,inc. | 3 | $276 |
| Novartis | 16 | $256 |
| Sight Sciences, Inc. | 12 | $213 |
| Bausch & Lomb Americas Inc. | 8 | $208 |
| Iridex Corporation | 3 | $203 |
| Kala Pharmaceuticals, Inc. | 12 | $194 |
| Glaukos Corporation | 2 | $185 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $184 |
| Rxsight Inc | 2 | $180 |
| Tearlab Corp | 1 | $174 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $126 |
| Dompe US, Inc. | 6 | $123 |
| Bausch Health US, LLC | 1 | $102 |
| Omeros Corporation | 5 | $102 |
| Rayner Intraocular Lenses Limited | 5 | $97 |
| Ivantis, Inc | 3 | $56 |
| Amgen | 3 | $52 |
| Quidel Corporation | 2 | $51 |
| Harrow Eye, LLC | 2 | $49 |
| Eyevance Pharmaceuticals LLC | 2 | $44 |
| Tarsus Pharmaceuticals, Inc. | 2 | $39 |
| Shire North American Group Inc | 2 | $38 |
| Biotissue Holdings Inc. | 2 | $38 |
| Thea Pharma Inc. | 1 | $35 |
| Carl Zeiss Meditec, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
| Eyepoint US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$554
- AcrySof$381
- Kahook Dual Blade$263
- Ahmed Glaucoma Valve$263
- TearLab Osmolarity System$174
- Clearpath$138
- Streamline$138
- Via360$138
- ReSTOR$131
- Streamline Surgical System$125
- AcrySof IQ VIVITY IOL$125
- AcrySof IQ PanOptix UV IOL$123
- RXSIGHT CONTACT LENS$113
- RXSIGHT INJECTOR CARTRIDGE$113
- RXSIGHT INJECTOR HANDPIECE$113
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$113
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$113
- iStent inject Trabecular Micro-Bypass Stent System$103
How this compares
$7,238 in reported general payments places this provider in the 80th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 81 | $86,166 |
| XiidraLifitegrast | 67 | $61,241 |
| LumiganBimatoprost | 86 | $38,301 |
| Cyclosporine | 58 | $30,012 |
| CombiganBrimonidine Tartrate/Timolol | 70 | $21,897 |
| RocklatanNetarsudil Mesylat/Latanoprost | 40 | $14,720 |
| Travoprost | 105 | $13,564 |
| Lotemax SmLoteprednol Etabonate | 52 | $13,287 |
| VyzultaLatanoprostene Bunod | 31 | $11,996 |
| RhopressaNetarsudil Mesylate | 30 | $10,864 |
| MieboPerfluorohexyloctane/Pf | 13 | $9,627 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 53 | $9,043 |
| Fluorometholone | 131 | $8,472 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 31 | $7,751 |
| Latanoprost | 915 | $6,888 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $445 | $152,148267 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta, Miebo | $208 | $82,865111 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $17 | $25,58470 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm, Prolensa, Loteprednol Etabonate | $184 | $22,385103 claims |
| AlconSimbrinza | $2,499 | $7,75131 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $751 | $6,19811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 293 ophthalmology providers in South Carolina.
Other ophthalmology in Clinton
- Harvard RiddleClinton$6K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Erik HappMt Pleasant$124K
- Matthew ClaryColumbia$119K
- Kunal KanitkarLexington$83K
- Carl SloanMyrtle Beach$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.